Rivastigmine for Refractory REM Behavior Disorder in Mild Cognitive Impairment

Abstract

Our data suggest that, in MCI patients with RBD resistant to conventional therapies (muscle relaxants benzodiazepines or melatonin,) treatment with RVT may induce a reduction in the frequency of RBD episodes compared to placebo.